IRCT20101130005280N55招募中3 期
Evaluating the Effectiveness of Adjunctive Therapy Using Folic Acid in Reducing Negative Symptoms of Male Schizophrenia Patients
Gorgan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Male
入选标准
- •Schizophrenia Diagnosis Based on V-DSM Diagnostic Criteria
- •Absence of Extrapyramidal Symptoms
- •Male Gender
- •Age Between 18 to 50 Years Old
- •Completing Informed Consent to Participate in the Study
排除标准
- •Clinically Prominent Neurological or Organic Disease
- •Presence of Another Major I-Axis Diagnosis Based on V-DSM
- •Abnormality in Previous Tests
- •IQ Less than 70 Based on Standardized Tests
- •History of Drug Use (Excluding Nicotine and Caffeine)
- •ECT in the Past Two Weeks
- •Oral Antipsychotics in the Past Week or Long-Acting Antipsychotics in the Past Month
研究者
相似试验
已完成
早期 1 期
The Effectiveness of the adjuvant treatment with a compound of sedge plant, saffron and honey to conventional treatment for improvement of cognitive performance of patients with dementiaIRCT2016101030255N1Vice Chancellor for research of Isfahan University of Medical Sciences60
尚未招募
3 期
Agnikarma and medicines in the pain management of knee osteoarthritisCTRI/2024/05/067894CCRAS, PG - STAR
进行中（未招募）
1 期
Evaluation of the benefit of using hydroxychloroquine for uncomplicated term pregnancy in patients with primary obstetric antiphospholipid syndromePrimary obstetrical antiphospholipid syndromeMedDRA version: 20.0Level: PTClassification code 10002817Term: Antiphospholipid syndromeSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2017-004866-86-FRASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)110
已完成
4 期
Adjunctive Medical Therapy with Oral Silodosin after Shock Wave Lithotripsy of Lower Ureteral Stone: A randomized controlled studyower ureteral stone after ESWLLower ureteral stone after ESWLRenal and Urogenital - Other renal and urogenital disordersACTRN12611000573954Chung Jing Wang45
已完成
2 期
Efficacy and Safety study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the Japanese patient with Stage III curative resection Colon cancer -Phase II studyColon cancerJPRN-UMIN000006742Multicenter Study Group of Osaka (MCSGO), Colorectal Cancer Treatment Group195